Pharmaceutical Executive March 18, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive video interview, Kaveh Vahdat, Founder and President of RiseOpp, discusses the impact AI will have on thelong-term well-being of founders and CEOs.

As AI continues to become an increasingly valuable tool at the C-suite level, both in and out of office, how do you envision this shift impacting the long-term well-being and sustainability of founders and CEOs?

I think in the short term is going to help in the long term, I have to think about it and I’m going to tell you about my perspective upon it. So, in the short term, what’s going to happen is that CEOs are repeat jobs, a lot of reporting, presentations, a lot of things that they need attention,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Employer, Technology, Trends
AI Investments Expected to Shift to Inference While Growing Faster Than Forecast
Report: OpenAI to Test Feature Connecting ChatGPT to Slack and Google Drive
Vaccines And AI
Mistral AI drops new open-source model that outperforms GPT-4o Mini with fraction of parameters
The most 'impactful' tech in 30 years? Ask Duke's health information chief

Share This Article